Fig 4. Individual drisapersen trough concentrations from weeks 72 to 184.
Subject 5 had an additional treatment break from weeks 101 to 128 inclusive. Subjects 1, 2, 5, 6, 7, 9, and 12 walked ≥330 m at extension study baseline; subjects 3, 4, 8 10, and 11 walked <330 m at extension study baseline. Grey shading is representative of off-treatment periods.
